Menu
Not yet recruiting NCT07250152

Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

— Observational Myocardial Infarction (MI)

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Percutaneous coronary intervention.
Who it may be relevant to
Registry conditions: Myocardial Infarction (MI). Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
China
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.

Interventions

  • Procedure Percutaneous coronary intervention
    Percutaneous coronary intervention

Primary outcome measures

  • Recurrent myocardial infarction or cardiac death [Time frame: At 24-month Follow-up]
  • Diagnostic performance [Time frame: At 24-month follow-up]
  • MACE at 24 months [Time frame: At 24-month follow-up]
Secondary outcome measures (1)
  • MACE at 60 months [Time frame: At 60-month follow-up]

Eligibility criteria

Inclusion criteria

  • Age ≥18 years old
  • Presented with myocardial infarction, including NSTEMI and STEMI
  • Undergoing successful percutaneous coronary intervention.

Exclusion criteria

  • Subjects who decline protocol-mandated follow-up or withhold informed consent.
  • Individuals whose expected survival is < 1 year.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

China · 1 center
  • The Second Affiliated Hospital of Zhejiang University School of Medicine — Hangzhou

Identifiers

NCT: NCT07250152 · 2025-1224

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗